EssilorLuxottica Societe Anonyme Total Assets 2011-2018 | ESLOY
EssilorLuxottica Societe Anonyme total assets from 2011 to 2018. Total assets can be defined as the sum of all assets on a company's balance sheet.
- EssilorLuxottica Societe Anonyme total assets for the quarter ending December 31, 2018 were $54.644B, a 275.14% increase year-over-year.
- EssilorLuxottica Societe Anonyme total assets for 2018 were $54.644B, a 293.04% increase from 2017.
- EssilorLuxottica Societe Anonyme total assets for 2017 were $13.903B, a 4.56% decline from 2016.
- EssilorLuxottica Societe Anonyme total assets for 2016 were $14.566B, a 9.58% increase from 2015.
| EssilorLuxottica Societe Anonyme Annual Total Assets (Millions of US $) |
|
|---|---|
| 2018 | $54,644 |
| 2017 | $13,903 |
| 2016 | $14,566 |
| 2015 | $13,293 |
| 2014 | $14,342 |
| 2013 | $10,065 |
| 2012 | $8,883 |
| 2011 | $8,577 |
| 2010 | $6,923 |
| EssilorLuxottica Societe Anonyme Quarterly Total Assets (Millions of US $) |
|
|---|---|
| Q4 2018 | $54,644 |
| Q2 2018 | $15,023 |
| Q4 2017 | $13,903 |
| Q2 2017 | $14,145 |
| Q4 2016 | $14,566 |
| Q4 2015 | $13,293 |
| Q2 2015 | $12,875 |
| Q4 2014 | $14,342 |
| Q2 2014 | $14,043 |
| Q4 2013 | $10,065 |
| Q2 2013 | $9,315 |
| Q4 2012 | $8,883 |
| Q2 2012 | $8,685 |
| Q4 2011 | $8,577 |
| Q2 2011 | $7,569 |
| Q4 2010 | $6,923 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $32.865B | $12.754B |
| EssilorLuxottica Soci?t? is involved in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses. The company's brand portfolio consists of Ray-Ban, Oakley, Varilux(R), Transitions(R), Sunglass Hut and LensCrafters. EssilorLuxottica Soci?t?, formerly known as Essilor International Soci?t? Anonyme, is based in Paris, France. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $146.323B | 26.71 |
| Medtronic (MDT) | Ireland | $145.061B | 20.36 |
| Stryker (SYK) | United States | $80.552B | 27.85 |
| Boston Scientific (BSX) | United States | $53.588B | 25.99 |
| Baxter (BAX) | United States | $44.924B | 27.24 |
| Zimmer Biomet Holdings (ZBH) | United States | $28.253B | 18.08 |
| Coloplast (CLPBY) | Denmark | $25.488B | 40.69 |
| Lonza Group Ag (LZAGY) | Switzerland | $25.356B | 0.00 |
| Terumo (TRUMY) | Japan | $24.335B | 0.00 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $20.897B | 0.00 |
| ResMed (RMD) | United States | $18.864B | 35.95 |
| Sunny Optical Technology (SNPTF) | China | $16.014B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $10.229B | 54.83 |
| Insulet (PODD) | United States | $9.266B | 549.07 |
| Perrigo (PRGO) | Ireland | $7.333B | 13.51 |
| Canopy Growth (CGC) | Canada | $7.030B | 0.00 |
| Hill-Rom Holdings (HRC) | United States | $6.817B | 20.33 |
| Haemonetics (HAE) | United States | $6.460B | 48.76 |
| William Demant Holdings (WILYY) | Denmark | $5.988B | 0.00 |
| GN STORE NORD (GNNDY) | Denmark | $5.344B | 27.61 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $4.296B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $3.786B | 0.00 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $3.648B | 0.00 |
| NuVasive (NUVA) | United States | $3.463B | 27.61 |
| Neogen (NEOG) | United States | $3.393B | 56.77 |
| ICU Medical (ICUI) | United States | $3.219B | 20.88 |
| Quidel (QDEL) | United States | $2.561B | 25.43 |
| Hutchison China MediTech (HCM) | Hong Kong, SAR China | $2.550B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.943B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.805B | 38.97 |
| Cardiovascular Systems (CSII) | United States | $1.730B | 0.00 |
| Aphria (APHA) | $1.197B | 0.00 | |
| VAREX IMAGING (VREX) | United States | $1.103B | 25.42 |
| AtriCure (ATRC) | United States | $1.057B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.853B | 13.88 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.843B | 21.50 |
| Omeros (OMER) | United States | $0.782B | 0.00 |
| NanoString Technologies (NSTG) | United States | $0.760B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $0.732B | 19.25 |
| LeMaitre Vascular (LMAT) | United States | $0.696B | 41.24 |
| PetIQ (PETQ) | United States | $0.676B | 15.98 |
| Cerus (CERS) | United States | $0.627B | 0.00 |
| Surmodics (SRDX) | United States | $0.605B | 114.95 |
| MacroGenics (MGNX) | United States | $0.538B | 0.00 |
| Quanterix (QTRX) | United States | $0.527B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.523B | 24.21 |
| TG Therapeutics (TGTX) | United States | $0.518B | 0.00 |
| Owens & Minor (OMI) | United States | $0.450B | 13.47 |
| Meridian Bioscience (VIVO) | United States | $0.428B | 13.37 |
| Utah Medical Products (UTMD) | United States | $0.356B | 26.11 |
| Zynex (ZYXI) | United States | $0.340B | 36.14 |
| BioLife Solutions (BLFS) | United States | $0.332B | 102.06 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.326B | 0.00 |
| United Health Products (UEEC) | United States | $0.242B | 0.00 |
| Bovie Medical (APYX) | United States | $0.229B | 0.00 |
| Vapotherm (VAPO) | United States | $0.180B | 0.00 |
| Repro-Med Systems (REPR) | United States | $0.163B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.158B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.146B | 0.00 |
| Female Health (VERU) | United States | $0.140B | 0.00 |
| Fonar (FONR) | United States | $0.130B | 9.14 |
| Liberty Health Sciences (LHSIF) | Canada | $0.106B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.094B | 0.00 |
| Chimerix (CMRX) | United States | $0.089B | 0.00 |
| United-Guardian (UG) | United States | $0.085B | 20.00 |
| Nephros (NEPH) | United States | $0.083B | 0.00 |
| MTech Acquisition (KERN) | United States | $0.062B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.053B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Surface Oncology (SURF) | United States | $0.037B | 0.00 |
| Senestech (SNES) | United States | $0.024B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.019B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.018B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.012B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.010B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.007B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.005B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.003B | 0.00 |
